Successful treatment of acute kidney allograft rejection using extracorporeal photopheresis in the context of post-transplant lymphoproliferative diseases: three successive cases.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 7 8 2021
medline: 15 12 2021
entrez: 6 8 2021
Statut: ppublish

Résumé

We reported 3 kidney transplant patients with PTLD who developed mixed AR following IS treatment minimization. AR episodes were treated with extracorporeal photopheresis (ECP), methylprednisolone and IVIG. In all patients, graft function improved under ECP and stabilized in the long term. These observations suggest that ECP is safe and efficient for treatment of AR in the context of PTLD.

Identifiants

pubmed: 34358369
doi: 10.1111/tri.14006
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

2415-2417

Informations de copyright

© 2021 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Références

Sprangers B, Riella LV, Dierickx D. Posttransplant lymphoproliferative disorder following kidney transplantation: a review. Am J Kidney Dis 2021; 78: 272.
Caillard S, Porcher R, Provot F, et al. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol 2013; 31: 1302.
Caillard S, Lamy FX, Quelen C, et al. Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas. Am J Transplant 2012; 12: 682.
Ahrens N, Geissler EK, Witt V, et al. European reflections on new indications for extracorporeal photopheresis in solid organ transplantation. Transplantation 2018; 102: 1279.
Knobler R, Arenberger P, Arun A, et al. European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2. J Eur Acad Dermatol Venereol 2021; 35: 27.
Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 2018; 378: 549.
Hannani D. Extracorporeal photopheresis: tolerogenic or immunogenic cell death? Beyond current dogma. Front Immunol 2015; 6: 349.
Pilon C, Stehlé T, Beldi-Ferchiou A, et al. Human apoptotic cells, generated by extracorporeal photopheresis. Modulate allogeneic immune response. Front Immunol 2019; 10: 2908.

Auteurs

Jean-François Augusto (JF)

Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France.
CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.

Philippe Gatault (P)

Service de Néphrologie et Immunologie Clinique, CHRU de Tours, Tours, France.

Johnny Sayegh (J)

Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France.

Anne-Sophie Garnier (AS)

Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France.

Agnès Duveau (A)

Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France.

Elodie Merieau (E)

Service de Néphrologie et Immunologie Clinique, CHRU de Tours, Tours, France.

Elodie Bailly (E)

Service de Néphrologie et Immunologie Clinique, CHRU de Tours, Tours, France.

Jean-François Subra (JF)

Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, CHU Angers, Angers, France.
CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.

Matthias Büchler (M)

Service de Néphrologie et Immunologie Clinique, CHRU de Tours, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH